(Q84624780)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21803109%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Stability of seasonal influenza vaccines investigated by spectroscopy and microscopy methods (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21803109%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

E Patois

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21803109%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

M A H Capelle

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21803109%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

R Gurny

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21803109%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

T Arvinte

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21803109%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

29 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21803109%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21803109%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21803109%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21803109%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

7404-7413

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21803109%20AND%20SRC:MED&resulttype=core&format=json

Influenza vaccine: the challenge of antigenic drift.

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Thermal stability of vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Stability of influenza sub-unit vaccine. Does a couple of days outside the refrigerator matter?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Physicochemical studies on the stability of influenza haemagglutinin in vaccine bulk material

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

The process development challenge for a new vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Stability of protein pharmaceuticals: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Stability of protein pharmaceuticals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Factors affecting short-term and long-term stabilities of proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Morphological and biochemical characterization of influenza vaccines commercially available in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Cervarix, the GSK HPV-16/HPV-18 AS04-adjuvanted cervical cancer vaccine, demonstrates stability upon long-term storage and under simulated cold chain break conditions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Structural and functional characterization of the Streptococcus pneumoniae RrgB pilus backbone D1 domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Identification, characterization and immunogenicity of an O-antigen capsular polysaccharide of Francisella tularensis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

New meningococcal C polysaccharide-tetanus toxoid conjugate Physico-chemical and immunological characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Biophysical characterization of influenza virus subpopulations using field flow fractionation and multiangle light scattering: correlation of particle counts, size distribution and infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Selective and quantitative detection of influenza virus proteins in commercial vaccines using two-dimensional high-performance liquid chromatography and fluorescence detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Approach to the profiling and characterization of influenza vaccine constituents by the combined use of size-exclusion chromatography, gel electrophoresis and mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Inflexal V a trivalent virosome subunit influenza vaccine: production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

The virosome concept for influenza vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Static light scattering from concentrated protein solutions II: experimental test of theory for protein mixtures and weakly self-associating proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Characterization of protein aggregation: the case of a therapeutic immunoglobulin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: correlation with antibody vaccine immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Preparing and evaluating delivery systems for proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Modulation of antigenicity related to changes in antibody flexibility upon lyophilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Characterization of oligomers during alpha-synuclein aggregation using intrinsic tryptophan fluorescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Biophysical characterization of insoluble aggregates of a multi-domain protein: an insight into the role of the various domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Structural stability of adenovirus type 5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

H1N1 Influenza Virus-Like Particles: Physical Degradation Pathways and Identification of Stabilizers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Detection and characterization of protein aggregates by fluorescence microscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: Basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009–2010 Northern Hemisphere season

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Toward understanding tryptophan fluorescence in proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Factors influencing cryoprotective activity and drug leakage from liposomes after freezing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Cellular proteins in influenza virus particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

A false paradise - mixed blessings in the protein universe: the amyloid as a new challenge in drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Principles, approaches, and challenges for predicting protein aggregation rates and shelf life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Protein misfolding and aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Protein aggregation: pathways, induction factors and analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Protein aggregation kinetics, mechanism, and curve-fitting: a review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Protein aggregation--pathways and influencing factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Protein aggregation and bioprocessing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6 cells: a novel RP-HPLC method.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

New vaccine approaches for seasonal and pandemic influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Aggregate content influences the Th1/Th2 immune response to influenza vaccine: evidence from a mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Cell-mediated protection in influenza infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Human immune responses to influenza virus vaccines administered by systemic or mucosal routes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Changing perspective on immunization against influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

A review of vaccine research and development: human acute respiratory infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

Understanding and increasing protein stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.067

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2011.07.067

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21803109%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference